top of page

Designing the Future of Medicine: CLUSTREL Joins UNIMORE's Colloquia in Bioengineering

Writer: CLUSTREL
CLUSTREL
Oct 14
2 min read

How can we prepare the next generation of bioengineers to transform scientific discoveries into medical technologies that make a difference? At the University of Modena and Reggio Emilia (UNIMORE), Colloquia in Bioengineering brings together academia, industry, and clinical expertise to explore this challenge. CLUSTREL’s partner Audrey Franceschi from SINDREL MedTech is going to give a lecture on drug delivery systems for neurological disorders.


A New Era for Bioengineering- Colloquia in Bioengineering

Medical technologies are evolving from predominantly passive devices toward intelligent, adaptive systems capable of interacting with biological processes at the cellular, molecular, and neural levels. Advances in neuroengineering, synthetic biology, advanced biomaterials, artificial intelligence, and precision medicine are opening new possibilities for diagnosing, monitoring, and treating disease. However, these developments also raise an important question: How do we prepare future bioengineers not only to understand emerging technologies, but also to bring them into clinical practice?


This question is central to Colloquia in Bioengineering, a course for the bioengineering students at the UNIMORE, coordinated by Prof. M. Giugliano, PhD.

Delivered through a series of expert lectures and interactive discussions, the course brings together prominent national and international speakers from academia, industry, entrepreneurship, and clinical practice.


Drug Delivery Systems for Neurological Disorders

As part of this programme, Audrey Franceschi Biagioni, PhD, researcher and entrepreneur of SINDREL MedTech, will give a lecture on Drug Delivery Systems for Neurological Disorders on 23 October 2026.


Neurological disorders present significant challenges for therapeutic development, particularly because of the complexity of the central nervous system and the biological barriers that can limit the delivery of therapeutic agents to their intended targets.


Innovative drug delivery technologies are an important area of biomedical research, with the potential to improve therapeutic targeting, optimise treatment strategies, and support the development of new approaches to neurological care. The lecture will bring this field into the broader conversation on bioengineering and translational medicine, highlighting the relevance of interdisciplinary research and innovation.


CLUSTREL’s technology is based on a non-invasive drug delivery device that could detect and prevent seizure. Using innovative technology and research to change the world. Participation in Colloquia in Bioengineering gives an opportunity to contribute to the education of future professionals and strengthen the dialogue between academic research and the biomedical innovation ecosystem.


At CLUSTREL, we value opportunities to connect scientific knowledge, innovation, and education, helping strengthen the foundations for future advances in biomedical engineering. The future of medicine is already taking shape. Preparing the people who will design it is just as important as developing the technologies themselves.


Course Information

Drug Delivery Systems for Neurological Disorders

Speaker: Audrey Franceschi Biagioni, PhD - Researcher and Founder of SINDREL MedTech

Date: Friday, 23 October 2026

Time: 08:30–13:30

Location: UNIMORE Faculty of Medicine and Surgery, Modena campus, Via Del Pozzo 71., Aula CS 1.1 - Centro Servizi


Stay updated on the CLUSTREL research development and progress by following the project on LinkedIn.

 
 
 

Comments


bottom of page